To assess the efficacy and safety of reserpine in reducing cocaine use in subjects with cocaine dependence. This is a double-blind, placebo-controlled, parallel-group design with a 2 week baseline period.
The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence.